Compare MLAB & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLAB | IGR |
|---|---|---|
| Founded | 1982 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 719.9M | 693.0M |
| IPO Year | 1995 | 2003 |
| Metric | MLAB | IGR |
|---|---|---|
| Price | $120.91 | $12.54 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $94.00 | N/A |
| AVG Volume (30 Days) | 134.5K | ★ 465.0K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | 0.67% | ★ 13.93% |
| EPS Growth | ★ 436.11 | N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $252.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.42 | $4.15 |
| 52 Week High | $132.70 | $13.67 |
| Indicator | MLAB | IGR |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 87.48 |
| Support Level | $94.20 | $4.50 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 4.22 | 0.14 |
| MACD | -1.03 | 0.96 |
| Stochastic Oscillator | 23.48 | 87.55 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.